NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.

P Rossignol,K Duarte,E Bresso,Åsberg A,M D Devignes,N Eriksson,N Girerd, R Glerup,A G Jardine,H Holdaas, Z Lamiral,C Leroy, Z Massy, W März, B Krämer,P H Wu, R Schmieder, I Soveri,J H Christensen,M Svensson,F Zannad,B Fellström

European heart journal open（2022）

引用 1|浏览25

暂无评分

摘要

Our findings suggest that NT-proBNP and SCF may help identify ESRD patients with respectively high and low CV risk, beyond classical clinical predictors and also point at novel pathways for prevention and treatment.

查看译文

关键词

Cardiovascular,Chronic hemodialysis,NT-proBNP,Prognosis,Stem cell factor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要